Progranulin and Amyloid-β Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer’s Disease
- 30 May 2015
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 46 (2) , 375-380
Abstract
Analysis of cerebrospinal fluid (CSF) has improved over the last few years; thus specific markers for different diseases have emerged, e.g., amyloid-β (Aβ) for Alzheimer's disease (AD) and progranulin for frontotemporal dementia (FTD). Evaluation of correlation between biomarkers in CSF and cognitive performance in populations with AD and FTD. 27 patients with AD and 16 with FTD were included. CSF tau, P-tau(181P), Aβ₄₂, and progranulin (PGRN) were measured and a standardized neuropsychological test battery applied. Olfactory testing was additionally included where available. For all patients across both groups, an association between PGRN and categoric (p = 0.016) and letter fluency (p = 0.029), naming (p = 0.003), and overall cognition (Mini-Mental State Examination: p = 0.04) was observed. Aβ42 was strongly associated with memory function (learning: p = 0.001; recall: p = 0.002). A correlation between Aβ₄₂ and memory performance was moreover found for each group separately, while PGRN also showed a correlation with recognition memory (p = 0.04) in AD. Furthermore, an association between reduced PGRN and olfactory dysfunction was revealed (p = 0.01). CSF-levels of PGRN and Aβ₄₂ levels express deficits in cognition differentially, with PGRN being predominantly associated with frontal and Aβ₄₂ with temporal dysfunction. This mirrors the cerebral occurrence of these proteins. These associations appear to be consistent across both disease groups. The relationship between PGRN and olfaction further underpins the association between PRGN and frontal dysfunction.Keywords
This publication has 24 references indexed in Scilit:
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family membersBrain, 2009
- Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degenerationNeurology, 2008
- Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer diseaseNeurology, 2008
- A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK seriesBrain, 2008
- Alzheimer and Parkinson Diagnoses in Progranulin Null Mutation Carriers in an Extended Founder FamilyArchives of Neurology, 2007
- Progranulin (acrogranin/PC cell‐derived growth factor/granulin‐epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine developmentDevelopmental Dynamics, 2003
- Olfaction in Neurodegenerative DiseaseArchives of Neurology, 1998
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984